Medivolve Inc. Stock NEO Exchange
Equities
MEDV
CA58503M4083
Advanced Medical Equipment & Technology
Sales 2022 | 37.18 50.67 | Sales 2023 | 0.69 0.94 | Capitalization | 390K 532K |
---|---|---|---|---|---|
Net income 2022 | -18M -24.53M | Net income 2023 | -16M -21.81M | EV / Sales 2022 | 22,108 x |
Net cash position 2022 | 2.64M 3.6M | Net Debt 2023 | 665K 906K | EV / Sales 2023 | 1,537,011 x |
P/E ratio 2022 |
-0.19
x | P/E ratio 2023 |
-0.02
x | Employees | 25 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.14% |
Managers | Title | Age | Since |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 21-04-29 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
1st Jan change | Capi. | |
---|---|---|
-5.81% | 29.31B | |
+36.58% | 9.09B | |
+32.48% | 4.4B | |
-40.24% | 2.26B | |
-9.44% | 1.6B | |
-28.89% | 1.23B | |
-43.59% | 966M | |
-10.86% | 798M | |
-49.77% | 699M |